PMV Pharmaceuticals, Inc. is developing first-in-class p53 regulators for the treatment of cancer. PMV Pharma combines unique biological understanding with pharmaceutical development focus.

Biotechnology

PMV Pharmaceuticals

David H. Mack

Asia Higgins

Yajuan Qin

J.D. Kern

Michael Carulli

Masha Poyurovsky

Shibu Sleeba

Crystal Zuckerman

Arshad Haque

Marc Fellous

Tim Smith

Binh Vu

Laura De Leon

Robert Ticktin

Deepika Jalota

Clinical Development and Operations

Leadership Team

Human Resources & Administration

Research and Development

Finance Team

Clinical Development and Medical Affairs

Regulatory and Quality Team

Teams at PMV Pharmaceuticals

Clinical Development and Operations

Leadership Team

Human Resources & Administration

Research and Development

Finance Team

Clinical Development and Medical Affairs

Regulatory and Quality Team